The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chinese Medicinal Materials Market Research Report 2024
Synopsis
The global Chinese Medicinal Materials market was valued at US$ 874 million in 2023 and is anticipated to reach US$ 1919.6 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
In 2023, the global pharmaceutical market will be about US$1.47 trillion, and the CAGR is expected to be about 5% in the next six years. The pharmaceutical market includes chemical drugs and biological drugs. Biologics will reach $381 billion in 2022. In contrast, the chemicals market is projected to increase from USD 1,005.6 billion in 2018 to USD 1,094 billion in 2022.
This report aims to provide a comprehensive presentation of the global market for Chinese Medicinal Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chinese Medicinal Materials.
Report Scope
The Chinese Medicinal Materials market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chinese Medicinal Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chinese Medicinal Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Yiling Pharmaceutical
China Traditional Chinese Medicine Holdings Co., Ltd.
Huisong Pharmaceuticals
Korea Ginseng Corporation
Daedong Korea Ginseng Co., Ltd.
Guangzhou Pharmaceutical
Yunnan Baiyao
TASLY
Kangmei Pharmaceutical Co. Ltd
Beijing Tong Ren Tang Co. Ltd
Henan Taloph Pharmaceutical Stock Co., Ltd
Guangdong Taiantang Pharmaceutical
BaiYunShan
Kanion Pharmaceutical
Jiangzhong Pharmaceutical
Buchang Pharma
Segment by Type
Plant-based Raw Materials
Animal Raw Materials
Mineral Raw Materials
Segment by Application
Food Addition
Pharmaceutical
Health Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chinese Medicinal Materials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chinese Medicinal Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Chinese Medicinal Materials market was valued at US$ 874 million in 2023 and is anticipated to reach US$ 1919.6 million by 2030, witnessing a CAGR of 11.8% during the forecast period 2024-2030.
In 2023, the global pharmaceutical market will be about US$1.47 trillion, and the CAGR is expected to be about 5% in the next six years. The pharmaceutical market includes chemical drugs and biological drugs. Biologics will reach $381 billion in 2022. In contrast, the chemicals market is projected to increase from USD 1,005.6 billion in 2018 to USD 1,094 billion in 2022.
This report aims to provide a comprehensive presentation of the global market for Chinese Medicinal Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chinese Medicinal Materials.
Report Scope
The Chinese Medicinal Materials market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chinese Medicinal Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chinese Medicinal Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Yiling Pharmaceutical
China Traditional Chinese Medicine Holdings Co., Ltd.
Huisong Pharmaceuticals
Korea Ginseng Corporation
Daedong Korea Ginseng Co., Ltd.
Guangzhou Pharmaceutical
Yunnan Baiyao
TASLY
Kangmei Pharmaceutical Co. Ltd
Beijing Tong Ren Tang Co. Ltd
Henan Taloph Pharmaceutical Stock Co., Ltd
Guangdong Taiantang Pharmaceutical
BaiYunShan
Kanion Pharmaceutical
Jiangzhong Pharmaceutical
Buchang Pharma
Segment by Type
Plant-based Raw Materials
Animal Raw Materials
Mineral Raw Materials
Segment by Application
Food Addition
Pharmaceutical
Health Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chinese Medicinal Materials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chinese Medicinal Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chinese Medicinal Materials Market Overview
1.1 Product Overview and Scope of Chinese Medicinal Materials
1.2 Chinese Medicinal Materials Segment by Type
1.2.1 Global Chinese Medicinal Materials Market Value Comparison by Type (2024-2030)
1.2.2 Plant-based Raw Materials
1.2.3 Animal Raw Materials
1.2.4 Mineral Raw Materials
1.3 Chinese Medicinal Materials Segment by Application
1.3.1 Global Chinese Medicinal Materials Market Value by Application: (2024-2030)
1.3.2 Food Addition
1.3.3 Pharmaceutical
1.3.4 Health Products
1.3.5 Others
1.4 Global Chinese Medicinal Materials Market Size Estimates and Forecasts
1.4.1 Global Chinese Medicinal Materials Revenue 2019-2030
1.4.2 Global Chinese Medicinal Materials Sales 2019-2030
1.4.3 Global Chinese Medicinal Materials Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chinese Medicinal Materials Market Competition by Manufacturers
2.1 Global Chinese Medicinal Materials Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chinese Medicinal Materials Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chinese Medicinal Materials Average Price by Manufacturers (2019-2024)
2.4 Global Chinese Medicinal Materials Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chinese Medicinal Materials, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chinese Medicinal Materials, Product Type & Application
2.7 Chinese Medicinal Materials Market Competitive Situation and Trends
2.7.1 Chinese Medicinal Materials Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chinese Medicinal Materials Players Market Share by Revenue
2.7.3 Global Chinese Medicinal Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chinese Medicinal Materials Retrospective Market Scenario by Region
3.1 Global Chinese Medicinal Materials Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chinese Medicinal Materials Global Chinese Medicinal Materials Sales by Region: 2019-2030
3.2.1 Global Chinese Medicinal Materials Sales by Region: 2019-2024
3.2.2 Global Chinese Medicinal Materials Sales by Region: 2025-2030
3.3 Global Chinese Medicinal Materials Global Chinese Medicinal Materials Revenue by Region: 2019-2030
3.3.1 Global Chinese Medicinal Materials Revenue by Region: 2019-2024
3.3.2 Global Chinese Medicinal Materials Revenue by Region: 2025-2030
3.4 North America Chinese Medicinal Materials Market Facts & Figures by Country
3.4.1 North America Chinese Medicinal Materials Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chinese Medicinal Materials Sales by Country (2019-2030)
3.4.3 North America Chinese Medicinal Materials Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chinese Medicinal Materials Market Facts & Figures by Country
3.5.1 Europe Chinese Medicinal Materials Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chinese Medicinal Materials Sales by Country (2019-2030)
3.5.3 Europe Chinese Medicinal Materials Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chinese Medicinal Materials Market Facts & Figures by Country
3.6.1 Asia Pacific Chinese Medicinal Materials Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chinese Medicinal Materials Sales by Country (2019-2030)
3.6.3 Asia Pacific Chinese Medicinal Materials Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chinese Medicinal Materials Market Facts & Figures by Country
3.7.1 Latin America Chinese Medicinal Materials Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chinese Medicinal Materials Sales by Country (2019-2030)
3.7.3 Latin America Chinese Medicinal Materials Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chinese Medicinal Materials Market Facts & Figures by Country
3.8.1 Middle East and Africa Chinese Medicinal Materials Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chinese Medicinal Materials Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chinese Medicinal Materials Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chinese Medicinal Materials Sales by Type (2019-2030)
4.1.1 Global Chinese Medicinal Materials Sales by Type (2019-2024)
4.1.2 Global Chinese Medicinal Materials Sales by Type (2025-2030)
4.1.3 Global Chinese Medicinal Materials Sales Market Share by Type (2019-2030)
4.2 Global Chinese Medicinal Materials Revenue by Type (2019-2030)
4.2.1 Global Chinese Medicinal Materials Revenue by Type (2019-2024)
4.2.2 Global Chinese Medicinal Materials Revenue by Type (2025-2030)
4.2.3 Global Chinese Medicinal Materials Revenue Market Share by Type (2019-2030)
4.3 Global Chinese Medicinal Materials Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chinese Medicinal Materials Sales by Application (2019-2030)
5.1.1 Global Chinese Medicinal Materials Sales by Application (2019-2024)
5.1.2 Global Chinese Medicinal Materials Sales by Application (2025-2030)
5.1.3 Global Chinese Medicinal Materials Sales Market Share by Application (2019-2030)
5.2 Global Chinese Medicinal Materials Revenue by Application (2019-2030)
5.2.1 Global Chinese Medicinal Materials Revenue by Application (2019-2024)
5.2.2 Global Chinese Medicinal Materials Revenue by Application (2025-2030)
5.2.3 Global Chinese Medicinal Materials Revenue Market Share by Application (2019-2030)
5.3 Global Chinese Medicinal Materials Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Yiling Pharmaceutical
6.1.1 Yiling Pharmaceutical Corporation Information
6.1.2 Yiling Pharmaceutical Description and Business Overview
6.1.3 Yiling Pharmaceutical Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Yiling Pharmaceutical Chinese Medicinal Materials Product Portfolio
6.1.5 Yiling Pharmaceutical Recent Developments/Updates
6.2 China Traditional Chinese Medicine Holdings Co., Ltd.
6.2.1 China Traditional Chinese Medicine Holdings Co., Ltd. Corporation Information
6.2.2 China Traditional Chinese Medicine Holdings Co., Ltd. Description and Business Overview
6.2.3 China Traditional Chinese Medicine Holdings Co., Ltd. Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.2.4 China Traditional Chinese Medicine Holdings Co., Ltd. Chinese Medicinal Materials Product Portfolio
6.2.5 China Traditional Chinese Medicine Holdings Co., Ltd. Recent Developments/Updates
6.3 Huisong Pharmaceuticals
6.3.1 Huisong Pharmaceuticals Corporation Information
6.3.2 Huisong Pharmaceuticals Description and Business Overview
6.3.3 Huisong Pharmaceuticals Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Huisong Pharmaceuticals Chinese Medicinal Materials Product Portfolio
6.3.5 Huisong Pharmaceuticals Recent Developments/Updates
6.4 Korea Ginseng Corporation
6.4.1 Korea Ginseng Corporation Corporation Information
6.4.2 Korea Ginseng Corporation Description and Business Overview
6.4.3 Korea Ginseng Corporation Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Korea Ginseng Corporation Chinese Medicinal Materials Product Portfolio
6.4.5 Korea Ginseng Corporation Recent Developments/Updates
6.5 Daedong Korea Ginseng Co., Ltd.
6.5.1 Daedong Korea Ginseng Co., Ltd. Corporation Information
6.5.2 Daedong Korea Ginseng Co., Ltd. Description and Business Overview
6.5.3 Daedong Korea Ginseng Co., Ltd. Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Daedong Korea Ginseng Co., Ltd. Chinese Medicinal Materials Product Portfolio
6.5.5 Daedong Korea Ginseng Co., Ltd. Recent Developments/Updates
6.6 Guangzhou Pharmaceutical
6.6.1 Guangzhou Pharmaceutical Corporation Information
6.6.2 Guangzhou Pharmaceutical Description and Business Overview
6.6.3 Guangzhou Pharmaceutical Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guangzhou Pharmaceutical Chinese Medicinal Materials Product Portfolio
6.6.5 Guangzhou Pharmaceutical Recent Developments/Updates
6.7 Yunnan Baiyao
6.6.1 Yunnan Baiyao Corporation Information
6.6.2 Yunnan Baiyao Description and Business Overview
6.6.3 Yunnan Baiyao Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yunnan Baiyao Chinese Medicinal Materials Product Portfolio
6.7.5 Yunnan Baiyao Recent Developments/Updates
6.8 TASLY
6.8.1 TASLY Corporation Information
6.8.2 TASLY Description and Business Overview
6.8.3 TASLY Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TASLY Chinese Medicinal Materials Product Portfolio
6.8.5 TASLY Recent Developments/Updates
6.9 Kangmei Pharmaceutical Co. Ltd
6.9.1 Kangmei Pharmaceutical Co. Ltd Corporation Information
6.9.2 Kangmei Pharmaceutical Co. Ltd Description and Business Overview
6.9.3 Kangmei Pharmaceutical Co. Ltd Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kangmei Pharmaceutical Co. Ltd Chinese Medicinal Materials Product Portfolio
6.9.5 Kangmei Pharmaceutical Co. Ltd Recent Developments/Updates
6.10 Beijing Tong Ren Tang Co. Ltd
6.10.1 Beijing Tong Ren Tang Co. Ltd Corporation Information
6.10.2 Beijing Tong Ren Tang Co. Ltd Description and Business Overview
6.10.3 Beijing Tong Ren Tang Co. Ltd Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Tong Ren Tang Co. Ltd Chinese Medicinal Materials Product Portfolio
6.10.5 Beijing Tong Ren Tang Co. Ltd Recent Developments/Updates
6.11 Henan Taloph Pharmaceutical Stock Co., Ltd
6.11.1 Henan Taloph Pharmaceutical Stock Co., Ltd Corporation Information
6.11.2 Henan Taloph Pharmaceutical Stock Co., Ltd Chinese Medicinal Materials Description and Business Overview
6.11.3 Henan Taloph Pharmaceutical Stock Co., Ltd Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Henan Taloph Pharmaceutical Stock Co., Ltd Chinese Medicinal Materials Product Portfolio
6.11.5 Henan Taloph Pharmaceutical Stock Co., Ltd Recent Developments/Updates
6.12 Guangdong Taiantang Pharmaceutical
6.12.1 Guangdong Taiantang Pharmaceutical Corporation Information
6.12.2 Guangdong Taiantang Pharmaceutical Chinese Medicinal Materials Description and Business Overview
6.12.3 Guangdong Taiantang Pharmaceutical Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Guangdong Taiantang Pharmaceutical Chinese Medicinal Materials Product Portfolio
6.12.5 Guangdong Taiantang Pharmaceutical Recent Developments/Updates
6.13 BaiYunShan
6.13.1 BaiYunShan Corporation Information
6.13.2 BaiYunShan Chinese Medicinal Materials Description and Business Overview
6.13.3 BaiYunShan Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.13.4 BaiYunShan Chinese Medicinal Materials Product Portfolio
6.13.5 BaiYunShan Recent Developments/Updates
6.14 Kanion Pharmaceutical
6.14.1 Kanion Pharmaceutical Corporation Information
6.14.2 Kanion Pharmaceutical Chinese Medicinal Materials Description and Business Overview
6.14.3 Kanion Pharmaceutical Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kanion Pharmaceutical Chinese Medicinal Materials Product Portfolio
6.14.5 Kanion Pharmaceutical Recent Developments/Updates
6.15 Jiangzhong Pharmaceutical
6.15.1 Jiangzhong Pharmaceutical Corporation Information
6.15.2 Jiangzhong Pharmaceutical Chinese Medicinal Materials Description and Business Overview
6.15.3 Jiangzhong Pharmaceutical Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangzhong Pharmaceutical Chinese Medicinal Materials Product Portfolio
6.15.5 Jiangzhong Pharmaceutical Recent Developments/Updates
6.16 Buchang Pharma
6.16.1 Buchang Pharma Corporation Information
6.16.2 Buchang Pharma Chinese Medicinal Materials Description and Business Overview
6.16.3 Buchang Pharma Chinese Medicinal Materials Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Buchang Pharma Chinese Medicinal Materials Product Portfolio
6.16.5 Buchang Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chinese Medicinal Materials Industry Chain Analysis
7.2 Chinese Medicinal Materials Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chinese Medicinal Materials Production Mode & Process
7.4 Chinese Medicinal Materials Sales and Marketing
7.4.1 Chinese Medicinal Materials Sales Channels
7.4.2 Chinese Medicinal Materials Distributors
7.5 Chinese Medicinal Materials Customers
8 Chinese Medicinal Materials Market Dynamics
8.1 Chinese Medicinal Materials Industry Trends
8.2 Chinese Medicinal Materials Market Drivers
8.3 Chinese Medicinal Materials Market Challenges
8.4 Chinese Medicinal Materials Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chinese Medicinal Materials Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chinese Medicinal Materials Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chinese Medicinal Materials Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chinese Medicinal Materials Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Chinese Medicinal Materials Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chinese Medicinal Materials Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chinese Medicinal Materials Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chinese Medicinal Materials Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chinese Medicinal Materials, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chinese Medicinal Materials, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chinese Medicinal Materials, Product Type & Application
Table 12. Global Key Manufacturers of Chinese Medicinal Materials, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chinese Medicinal Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chinese Medicinal Materials as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chinese Medicinal Materials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chinese Medicinal Materials Sales by Region (2019-2024) & (K Units)
Table 18. Global Chinese Medicinal Materials Sales Market Share by Region (2019-2024)
Table 19. Global Chinese Medicinal Materials Sales by Region (2025-2030) & (K Units)
Table 20. Global Chinese Medicinal Materials Sales Market Share by Region (2025-2030)
Table 21. Global Chinese Medicinal Materials Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chinese Medicinal Materials Revenue Market Share by Region (2019-2024)
Table 23. Global Chinese Medicinal Materials Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chinese Medicinal Materials Revenue Market Share by Region (2025-2030)
Table 25. North America Chinese Medicinal Materials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chinese Medicinal Materials Sales by Country (2019-2024) & (K Units)
Table 27. North America Chinese Medicinal Materials Sales by Country (2025-2030) & (K Units)
Table 28. North America Chinese Medicinal Materials Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chinese Medicinal Materials Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chinese Medicinal Materials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chinese Medicinal Materials Sales by Country (2019-2024) & (K Units)
Table 32. Europe Chinese Medicinal Materials Sales by Country (2025-2030) & (K Units)
Table 33. Europe Chinese Medicinal Materials Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chinese Medicinal Materials Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chinese Medicinal Materials Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chinese Medicinal Materials Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Chinese Medicinal Materials Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Chinese Medicinal Materials Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chinese Medicinal Materials Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chinese Medicinal Materials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chinese Medicinal Materials Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Chinese Medicinal Materials Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Chinese Medicinal Materials Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chinese Medicinal Materials Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chinese Medicinal Materials Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chinese Medicinal Materials Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Chinese Medicinal Materials Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Chinese Medicinal Materials Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chinese Medicinal Materials Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chinese Medicinal Materials Sales (K Units) by Type (2019-2024)
Table 51. Global Chinese Medicinal Materials Sales (K Units) by Type (2025-2030)
Table 52. Global Chinese Medicinal Materials Sales Market Share by Type (2019-2024)
Table 53. Global Chinese Medicinal Materials Sales Market Share by Type (2025-2030)
Table 54. Global Chinese Medicinal Materials Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chinese Medicinal Materials Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chinese Medicinal Materials Revenue Market Share by Type (2019-2024)
Table 57. Global Chinese Medicinal Materials Revenue Market Share by Type (2025-2030)
Table 58. Global Chinese Medicinal Materials Price (US$/Unit) by Type (2019-2024)
Table 59. Global Chinese Medicinal Materials Price (US$/Unit) by Type (2025-2030)
Table 60. Global Chinese Medicinal Materials Sales (K Units) by Application (2019-2024)
Table 61. Global Chinese Medicinal Materials Sales (K Units) by Application (2025-2030)
Table 62. Global Chinese Medicinal Materials Sales Market Share by Application (2019-2024)
Table 63. Global Chinese Medicinal Materials Sales Market Share by Application (2025-2030)
Table 64. Global Chinese Medicinal Materials Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chinese Medicinal Materials Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chinese Medicinal Materials Revenue Market Share by Application (2019-2024)
Table 67. Global Chinese Medicinal Materials Revenue Market Share by Application (2025-2030)
Table 68. Global Chinese Medicinal Materials Price (US$/Unit) by Application (2019-2024)
Table 69. Global Chinese Medicinal Materials Price (US$/Unit) by Application (2025-2030)
Table 70. Yiling Pharmaceutical Corporation Information
Table 71. Yiling Pharmaceutical Description and Business Overview
Table 72. Yiling Pharmaceutical Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Yiling Pharmaceutical Chinese Medicinal Materials Product
Table 74. Yiling Pharmaceutical Recent Developments/Updates
Table 75. China Traditional Chinese Medicine Holdings Co., Ltd. Corporation Information
Table 76. China Traditional Chinese Medicine Holdings Co., Ltd. Description and Business Overview
Table 77. China Traditional Chinese Medicine Holdings Co., Ltd. Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. China Traditional Chinese Medicine Holdings Co., Ltd. Chinese Medicinal Materials Product
Table 79. China Traditional Chinese Medicine Holdings Co., Ltd. Recent Developments/Updates
Table 80. Huisong Pharmaceuticals Corporation Information
Table 81. Huisong Pharmaceuticals Description and Business Overview
Table 82. Huisong Pharmaceuticals Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Huisong Pharmaceuticals Chinese Medicinal Materials Product
Table 84. Huisong Pharmaceuticals Recent Developments/Updates
Table 85. Korea Ginseng Corporation Corporation Information
Table 86. Korea Ginseng Corporation Description and Business Overview
Table 87. Korea Ginseng Corporation Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Korea Ginseng Corporation Chinese Medicinal Materials Product
Table 89. Korea Ginseng Corporation Recent Developments/Updates
Table 90. Daedong Korea Ginseng Co., Ltd. Corporation Information
Table 91. Daedong Korea Ginseng Co., Ltd. Description and Business Overview
Table 92. Daedong Korea Ginseng Co., Ltd. Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Daedong Korea Ginseng Co., Ltd. Chinese Medicinal Materials Product
Table 94. Daedong Korea Ginseng Co., Ltd. Recent Developments/Updates
Table 95. Guangzhou Pharmaceutical Corporation Information
Table 96. Guangzhou Pharmaceutical Description and Business Overview
Table 97. Guangzhou Pharmaceutical Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Guangzhou Pharmaceutical Chinese Medicinal Materials Product
Table 99. Guangzhou Pharmaceutical Recent Developments/Updates
Table 100. Yunnan Baiyao Corporation Information
Table 101. Yunnan Baiyao Description and Business Overview
Table 102. Yunnan Baiyao Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Yunnan Baiyao Chinese Medicinal Materials Product
Table 104. Yunnan Baiyao Recent Developments/Updates
Table 105. TASLY Corporation Information
Table 106. TASLY Description and Business Overview
Table 107. TASLY Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. TASLY Chinese Medicinal Materials Product
Table 109. TASLY Recent Developments/Updates
Table 110. Kangmei Pharmaceutical Co. Ltd Corporation Information
Table 111. Kangmei Pharmaceutical Co. Ltd Description and Business Overview
Table 112. Kangmei Pharmaceutical Co. Ltd Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Kangmei Pharmaceutical Co. Ltd Chinese Medicinal Materials Product
Table 114. Kangmei Pharmaceutical Co. Ltd Recent Developments/Updates
Table 115. Beijing Tong Ren Tang Co. Ltd Corporation Information
Table 116. Beijing Tong Ren Tang Co. Ltd Description and Business Overview
Table 117. Beijing Tong Ren Tang Co. Ltd Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Beijing Tong Ren Tang Co. Ltd Chinese Medicinal Materials Product
Table 119. Beijing Tong Ren Tang Co. Ltd Recent Developments/Updates
Table 120. Henan Taloph Pharmaceutical Stock Co., Ltd Corporation Information
Table 121. Henan Taloph Pharmaceutical Stock Co., Ltd Description and Business Overview
Table 122. Henan Taloph Pharmaceutical Stock Co., Ltd Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Henan Taloph Pharmaceutical Stock Co., Ltd Chinese Medicinal Materials Product
Table 124. Henan Taloph Pharmaceutical Stock Co., Ltd Recent Developments/Updates
Table 125. Guangdong Taiantang Pharmaceutical Corporation Information
Table 126. Guangdong Taiantang Pharmaceutical Description and Business Overview
Table 127. Guangdong Taiantang Pharmaceutical Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Guangdong Taiantang Pharmaceutical Chinese Medicinal Materials Product
Table 129. Guangdong Taiantang Pharmaceutical Recent Developments/Updates
Table 130. BaiYunShan Corporation Information
Table 131. BaiYunShan Description and Business Overview
Table 132. BaiYunShan Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. BaiYunShan Chinese Medicinal Materials Product
Table 134. BaiYunShan Recent Developments/Updates
Table 135. Kanion Pharmaceutical Corporation Information
Table 136. Kanion Pharmaceutical Description and Business Overview
Table 137. Kanion Pharmaceutical Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Kanion Pharmaceutical Chinese Medicinal Materials Product
Table 139. Kanion Pharmaceutical Recent Developments/Updates
Table 140. Jiangzhong Pharmaceutical Corporation Information
Table 141. Jiangzhong Pharmaceutical Description and Business Overview
Table 142. Jiangzhong Pharmaceutical Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Jiangzhong Pharmaceutical Chinese Medicinal Materials Product
Table 144. Jiangzhong Pharmaceutical Recent Developments/Updates
Table 145. Buchang Pharma Corporation Information
Table 146. Buchang Pharma Description and Business Overview
Table 147. Buchang Pharma Chinese Medicinal Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Buchang Pharma Chinese Medicinal Materials Product
Table 149. Buchang Pharma Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Chinese Medicinal Materials Distributors List
Table 153. Chinese Medicinal Materials Customers List
Table 154. Chinese Medicinal Materials Market Trends
Table 155. Chinese Medicinal Materials Market Drivers
Table 156. Chinese Medicinal Materials Market Challenges
Table 157. Chinese Medicinal Materials Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chinese Medicinal Materials
Figure 2. Global Chinese Medicinal Materials Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chinese Medicinal Materials Market Share by Type in 2023 & 2030
Figure 4. Plant-based Raw Materials Product Picture
Figure 5. Animal Raw Materials Product Picture
Figure 6. Mineral Raw Materials Product Picture
Figure 7. Global Chinese Medicinal Materials Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Chinese Medicinal Materials Market Share by Application in 2023 & 2030
Figure 9. Food Addition
Figure 10. Pharmaceutical
Figure 11. Health Products
Figure 12. Others
Figure 13. Global Chinese Medicinal Materials Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Chinese Medicinal Materials Market Size (2019-2030) & (US$ Million)
Figure 15. Global Chinese Medicinal Materials Sales (2019-2030) & (K Units)
Figure 16. Global Chinese Medicinal Materials Average Price (US$/Unit) & (2019-2030)
Figure 17. Chinese Medicinal Materials Report Years Considered
Figure 18. Chinese Medicinal Materials Sales Share by Manufacturers in 2023
Figure 19. Global Chinese Medicinal Materials Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Chinese Medicinal Materials Players: Market Share by Revenue in 2023
Figure 21. Chinese Medicinal Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Chinese Medicinal Materials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Chinese Medicinal Materials Sales Market Share by Country (2019-2030)
Figure 24. North America Chinese Medicinal Materials Revenue Market Share by Country (2019-2030)
Figure 25. United States Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Chinese Medicinal Materials Sales Market Share by Country (2019-2030)
Figure 28. Europe Chinese Medicinal Materials Revenue Market Share by Country (2019-2030)
Figure 29. Germany Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Chinese Medicinal Materials Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Chinese Medicinal Materials Revenue Market Share by Region (2019-2030)
Figure 36. China Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Chinese Medicinal Materials Sales Market Share by Country (2019-2030)
Figure 44. Latin America Chinese Medicinal Materials Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Chinese Medicinal Materials Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Chinese Medicinal Materials Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Chinese Medicinal Materials Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Chinese Medicinal Materials by Type (2019-2030)
Figure 54. Global Revenue Market Share of Chinese Medicinal Materials by Type (2019-2030)
Figure 55. Global Chinese Medicinal Materials Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Chinese Medicinal Materials by Application (2019-2030)
Figure 57. Global Revenue Market Share of Chinese Medicinal Materials by Application (2019-2030)
Figure 58. Global Chinese Medicinal Materials Price (US$/Unit) by Application (2019-2030)
Figure 59. Chinese Medicinal Materials Value Chain
Figure 60. Chinese Medicinal Materials Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
